$10.9 Billion is the total value of HHLR ADVISORS, LTD.'s 74 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $62,475,000 | – | 1,100,495 | +100.0% | 0.57% | – |
| OTIS | New | OTIS WORLDWIDE CORP | $34,944,000 | – | 614,556 | +100.0% | 0.32% | – |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $34,256,000 | – | 800,000 | +100.0% | 0.31% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $27,664,000 | – | 650,000 | +100.0% | 0.25% | – |
| NVAX | New | NOVAVAX INC | $27,175,000 | – | 326,038 | +100.0% | 0.25% | – |
| ADCT | New | ADC THERAPEUTICS SA | $23,405,000 | – | 500,000 | +100.0% | 0.21% | – |
| FMTX | New | FORMA THERAPEUTICS HLDGS INC | $23,245,000 | – | 500,000 | +100.0% | 0.21% | – |
| YY | New | JOYY INC | $21,206,000 | – | 239,476 | +100.0% | 0.19% | – |
| RNA | New | AVIDITY BIOSCIENCES INC | $12,011,000 | – | 425,000 | +100.0% | 0.11% | – |
| BNR | New | BURNING ROCK BIOTECH LTDsponsored ads | $10,804,000 | – | 400,000 | +100.0% | 0.10% | – |
| CALT | New | CALLIDITAS THERAPEUTICS ABsponsered ads | $8,155,000 | – | 350,000 | +100.0% | 0.08% | – |
| LPTX | New | LEAP THERAPEUTICS INC | $7,532,000 | – | 3,604,040 | +100.0% | 0.07% | – |
| KDP | New | KEURIG DR PEPPER INC | $6,008,000 | – | 211,556 | +100.0% | 0.06% | – |
| GDS | New | GDS HLDGS LTDsponsored ads | $5,313,000 | – | 66,700 | +100.0% | 0.05% | – |
| HTHT | New | HUAZHU GROUP LTDsponsored ads | $4,514,000 | – | 128,786 | +100.0% | 0.04% | – |
| API | New | AGORA INCads | $1,327,000 | – | 30,050 | +100.0% | 0.01% | – |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $382,000 | – | 124,970 | +100.0% | 0.00% | – |
| SFUN | New | FANG HLDGS LTDadr new | $340,000 | – | 30,000 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.